VAL‐1221 vs alglucosidase alfaQoL · adults with LOPDThe review found no eligible studies for this question.1 finding from 1 reviewEnzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found